These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37111649)

  • 1. Molecular Interactions between APIs and Enteric Polymeric Excipients in Solid Dispersion: Insights from Molecular Simulations and Experiments.
    Gupta KM; Chin X; Kanaujia P
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent-Assisted Hot Melt Extrusion of a Thermally Labile, High Melting Point Compound.
    Lagan C; Huckle JE; Katz JM; Khorsand B; Daurio D; Andrews GP; Chung J; Alvarez-Nunez F
    AAPS PharmSciTech; 2021 Sep; 22(7):235. PubMed ID: 34498147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing Drug Loading of Weakly Acidic Telmisartan in Amorphous Solid Dispersions through pH Modification during Hot-Melt Extrusion.
    Thompson SA; Davis DA; Moon C; Williams RO
    Mol Pharm; 2022 Jan; 19(1):318-331. PubMed ID: 34846902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.
    Kyeremateng SO; Voges K; Dohrn S; Sobich E; Lander U; Weber S; Gessner D; Evans RC; Degenhardt M
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the Molecular-Level Interactions in an Active Pharmaceutical Ingredient (API) - Polymer Dispersion and the Resulting Impact on Drug Product Formulation.
    Yang F; Su Y; Small J; Huang C; Martin GE; Farrington AM; DiNunzio J; Brown CD
    Pharm Res; 2020 May; 37(6):94. PubMed ID: 32405662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
    Pavliš J; Mathers A; Fulem M; Klajmon M
    Mol Pharm; 2023 Aug; 20(8):3960-3974. PubMed ID: 37386723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
    Zhang S; Xu X; Sun W; Zhang Z; Pan B; Hu Q
    Eur J Pharm Sci; 2022 Jan; 168():106074. PubMed ID: 34798261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Material-Sparing Feasibility Screening for Hot Melt Extrusion.
    Pluntze A; Beecher S; Anderson M; Wright D; Mudie D
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ball milling and hot-melt extrusion of indomethacin-l-arginine-vinylpyrrolidone-vinyl acetate copolymer: Solid-state properties and dissolution performance.
    Iemtsev A; Zemánková A; Hassouna F; Mathers A; Klajmon M; Slámová M; Malinová L; Fulem M
    Int J Pharm; 2022 Feb; 613():121424. PubMed ID: 34968683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API solubility in semi-crystalline polymer: Kinetic and thermodynamic phase behavior of PVA-based solid dispersions.
    Mathers A; Pechar M; Hassouna F; Fulem M
    Int J Pharm; 2022 Jul; 623():121855. PubMed ID: 35623485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Model-Based Melt Viscosity in Hot-Melt Extrusion Numerical Simulation.
    Bochmann ES; Gryczke A; Wagner KG
    Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30126193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.
    Shikha S; Lee YW; Doyle PS; Khan SA
    Mol Pharm; 2022 Nov; 19(11):4345-4356. PubMed ID: 36268657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.